Jiana Jia

Title: Jiana Jia - Innovator in Tumor-Targeting Therapeutics

Introduction

Jiana Jia is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions for cancer treatment. Her work focuses on creating bispecific recombinant proteins that enhance the efficacy of tumor-targeting therapies.

Latest Patents

Jiana Jia holds a patent for a bispecific recombinant protein and its applications. This invention comprises a high affinity tumor-targeting arm and a low affinity fusion protein that blocks the interaction of CD47 with SIRPα. The antibody corresponding to the high affinity tumor-targeting arm does not bind to CD47, and its binding affinity to the target antigen on the tumor cell is at least six times greater than that of the monomer fusion protein homodimer corresponding to the low affinity fusion protein. This innovative approach aims to improve the treatment of tumors by utilizing nucleic acid molecules that encode recombinant proteins.

Career Highlights

Jiana Jia is associated with Shanghai JMT-Bio Technology Co., Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes.

Collaborations

Jiana collaborates with notable colleagues, including Liping Song and Xiaotian Cui, who contribute to her research initiatives and help drive innovation in the field.

Conclusion

Jiana Jia's contributions to biotechnology, particularly in the development of bispecific recombinant proteins, highlight her role as a key innovator in cancer treatment. Her work promises to pave the way for more effective therapeutic options for patients battling tumors.